Breaking News Instant updates and real-time market news.

ONCE

Spark Therapeutics

$47.72

-25.66 (-34.97%)

10:54
12/12/17
12/12
10:54
12/12/17
10:54

Spark Therapeutics upgraded to Neutral from Underperform at Wedbush

  • 14

    Dec

  • 12

    Jan

ONCE Spark Therapeutics
$47.72

-25.66 (-34.97%)

12/12/17
LEER
12/12/17
DOWNGRADE
Target $49
LEER
Market Perform
Spark Therapeutics downgraded to Market Perform from Outperform at Leerink
Leerink analyst Joseph Schwartz downgraded Spark Therapeutics (ONCE) to Market Perform and cut his price target for the shares to $49 from $97. UBS this morning also downgraded the shares. The loss of expression and erratic responses to date indicate it will be more difficult for Spark's SPK-8011 to differentiate itself favorably relative to BioMarin's (BMRN) Valrox, Schwartz tells investors in a research note. The analyst sees a low likelihood that the next SPK-8011 data provides a clear picture of efficacy.
12/12/17
BMOC
12/12/17
NO CHANGE
Target $73
BMOC
Outperform
Spark Therapeutics price target lowered to $73 from $101 at BMO Capital
BMO Capital analyst Matthew Luchini cut his price target on Spark Therapeutics to $73 after its update on SPK-8011 failed to show a dose response and potential need for concomitant steroids. Luchini also lowered his probability of success for the treatment to 15% from 45% while extending its timeline for potential launch to 2022. The analyst keeps his Outperform rating on Spark Therapeutics, saying the current weakness is overdone thanks to support from its hemophilia B gene therapy and Luxturna programs.
12/12/17
BERN
12/12/17
NO CHANGE
BERN
Spark Therapeutics should be bought on weakness, says Bernstein
Bernstein analyst Vincent Chen notes that while BioMarin (BMRN) hemophilia gene therapy data was as expected, Spark Therapeutics' (ONCE) data was quite confounding. Nonetheless, he thinks the stock reaction is overdone. Spark's results are not positive, but he would not write off SPK-8011 or the platform. Chen says he would buy on weakness.
12/12/17
12/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Juno Therapeutics (JUNO) downgraded to Market Perform from Outperform at Wells Fargo, with analyst Jim Birchenough saying that while data for JCAR017 continue to support a potential best-in-class profile in aggressive lymphoma, the current valuation already reflects dominant market positioning over Gilead's (GILD) Yescarta. 2. General Dynamics (GD) downgraded to Underweight from Neutral at JPMorgan, with analyst Seth Seifman saying Gulfstream questions are unlikely to be resolved in the near term. Demand for G500/600 is ok for now, but uncertainty about ultimate production levels and the pace of the learning curve mean the transition will remain a near term overhang, the analyst said. Seifman also downgraded Raytheon (RTN) to Neutral from Underweight. 3. Adobe (ADBE), Barracuda (CUDA), GoDaddy (GDDY), Fortinet (FTNT) and Check Point (CHKP) downgraded to Neutral from Overweight and CoStar Group (CSGP), Imperva (IMPV) and Monotype Imaging (TYPE) downgraded to Underweight from Overweight at JPMorgan by analyst Sterling Auty in conjunction with his 2018 annual outlook for Software Technology. The analyst does not expect the "exceptional performance" in Software during 2017 to repeat in 2018. 4. Spark Therapeutics (ONCE) downgraded to Neutral from Buy at UBS, with analyst Carter Gould seeing a "challenging setup" for the shares after the Phase 1/2 SPK-8011 data in hemophilia A fell short of expectations. The analyst removed SPK-8011, or $29 per share, and early-stage pipeline value, or $12 per share, from his model. He finds it difficult to be more constructive on Spark shares in the near-term. 5. Electronic Arts (EA) downgraded to Buy from Conviction Buy at Goldman Sachs by analyst Christopher Merwin to reflect fewer near-term catalysts around in-game monetization of non-sports titles. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NFLX

Netflix

09:28
10/17/18
10/17
09:28
10/17/18
09:28
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TPR

Tapestry

$44.48

1.39 (3.23%)

09:27
10/17/18
10/17
09:27
10/17/18
09:27
Upgrade
Tapestry rating change  »

Tapestry upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NFLX

Netflix

$346.40

13.29 (3.99%)

09:26
10/17/18
10/17
09:26
10/17/18
09:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PVTL

Pivotal Software

$19.94

1.44 (7.78%)

09:25
10/17/18
10/17
09:25
10/17/18
09:25
Hot Stocks
Pivotal Software weakness attributed to lock-up expiration »

Shares of Pivotal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$158.81

5.25 (3.42%)

09:25
10/17/18
10/17
09:25
10/17/18
09:25
Periodicals
Facebook Watch lands The Real World from MTV, Deadline reports »

Facebook Watch will now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

COOP

Mr. Cooper

$15.22

-0.39 (-2.50%)

09:24
10/17/18
10/17
09:24
10/17/18
09:24
Recommendations
Mr. Cooper analyst commentary  »

Mr. Cooper price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSX

Diana Shipping

$3.95

0.07 (1.80%)

, GLNCY

Glencore

$0.00

(0.00%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Diana Shipping reports continuation of time charter contract with Glencore »

Diana Shipping (DSX)…

DSX

Diana Shipping

$3.95

0.07 (1.80%)

GLNCY

Glencore

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEON

Neonode

$2.90

0.355 (13.95%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Neonode regains compliance with Nasdaq minimum bid price requirement »

Neonode received a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.89

0.195 (7.25%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Hot Stocks
Kadmon announces FDA breakthrough therapy designation granted to KD025 »

Kadmon announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$145.02

3.9 (2.76%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23
Recommendations
IBM analyst commentary  »

IBM price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

GPN

Global Payments

$119.87

4.42 (3.83%)

09:22
10/17/18
10/17
09:22
10/17/18
09:22
Recommendations
Global Payments analyst commentary  »

Global Payments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

HD

Home Depot

$193.61

2.51 (1.31%)

, LOW

Lowe's

$105.97

1.31 (1.25%)

09:21
10/17/18
10/17
09:21
10/17/18
09:21
Downgrade
Home Depot, Lowe's rating change  »

Home Depot, Lowe's…

HD

Home Depot

$193.61

2.51 (1.31%)

LOW

Lowe's

$105.97

1.31 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

GWW

Grainger

$280.03

-38.35 (-12.05%)

09:20
10/17/18
10/17
09:20
10/17/18
09:20
Recommendations
Grainger analyst commentary  »

Grainger selloff may be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

HAIR

Restoration Robotics

$1.79

-0.04 (-2.19%)

09:19
10/17/18
10/17
09:19
10/17/18
09:19
Hot Stocks
Restoration Robotics announces results of ARTAS iX case study at ASDS »

Restoration Robotics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

IBM

IBM

$145.02

3.9 (2.76%)

09:18
10/17/18
10/17
09:18
10/17/18
09:18
Technical Analysis
Technical Take: IBM hits fresh 52-week low after earnings disappoint »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/17/18
10/17
09:18
10/17/18
09:18
Options
Overnight activity included 287 trades in SPX and 3 trades in VIX »

287 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$18.88

0.76 (4.19%)

09:17
10/17/18
10/17
09:17
10/17/18
09:17
Recommendations
Marvell analyst commentary  »

Marvell management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$33.43

1.84 (5.82%)

09:17
10/17/18
10/17
09:17
10/17/18
09:17
Recommendations
Boingo Wireless analyst commentary  »

Boingo Wireless price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ABT

Abbott

$70.94

2.22 (3.23%)

09:16
10/17/18
10/17
09:16
10/17/18
09:16
Earnings
Breaking Earnings news story on Abbott »

Abbott sees FY18 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ABT

Abbott

$70.94

2.22 (3.23%)

09:16
10/17/18
10/17
09:16
10/17/18
09:16
Earnings
Breaking Earnings news story on Abbott »

Abbott sees Q4 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ODP

Office Depot

$2.85

0.005 (0.18%)

, WPP

WPP

$69.83

0.59 (0.85%)

09:15
10/17/18
10/17
09:15
10/17/18
09:15
Hot Stocks
Office Depot expands marketing agency of record with WPP »

Office Depot (ODP) and…

ODP

Office Depot

$2.85

0.005 (0.18%)

WPP

WPP

$69.83

0.59 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRTEA

Qurate Retail

$21.94

0.32 (1.48%)

09:15
10/17/18
10/17
09:15
10/17/18
09:15
Hot Stocks
Qurate Retail announces long-term iniatitives »

Qurate Retail Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 14

    Nov

CREE

Cree

$37.56

2.53 (7.22%)

09:14
10/17/18
10/17
09:14
10/17/18
09:14
Recommendations
Cree analyst commentary  »

Cree focus on tightening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGI

Renewable Energy

$29.86

1.31 (4.59%)

09:14
10/17/18
10/17
09:14
10/17/18
09:14
Recommendations
Renewable Energy analyst commentary  »

Renewable Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

PE

Parsley Energy

$29.70

0.7 (2.41%)

09:14
10/17/18
10/17
09:14
10/17/18
09:14
Downgrade
Parsley Energy rating change  »

Parsley Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.